抑制PCSK9通过减少通过LDLR/STAT-3/ROR-γt通路的Th17细胞分化来改善实验性自身免疫心肌炎
Miao Yu1, Wenjing Tang1, Wei Liang1
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
International immunopharmacology
|September 30, 2023
概括
在实验性自身免疫性心肌炎中,蛋白转化酶 (subtilisin kexin type 9) (PCSK9) 抑制减少了心脏炎症. 阻断PCSK9降低了Th17细胞分化,这表明PCSK9是心肌炎的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管研究研究心血管研究
- 分子生物学分子生物学
背景情况:
- 众所周知,蛋白转化酶子素素9型 (PCSK9) 有关胆固醇的调节作用.
- 新兴证据将PCSK9与超出脂质代谢的炎症和自身免疫性疾病联系起来.
- 在心肌炎中PCSK9的作用仍然在很大程度上未被探索.
研究的目的:
- 研究PCSK9在实验性自身免疫性心肌炎 (EAM) 中的作用和潜在机制.
- 评估PCSK9抑制在改善心肌炎中的治疗潜力.
主要方法:
- 使用MyHC-α免疫建立了一个EAM小鼠模型.
- 在EAM小鼠中使用PCSK9抑制剂 (evolocumab).
- 评估心脏炎症,PCSK9水平,免疫细胞群 (CD4 +,CD8 + T 细胞,巨细胞) 和心肌细胞参与.
- 对CD4+T细胞进行了体外研究,以阐明PCSK9通过LDLR/STAT3/ROR-γt通路对Th17分化的机制.
主要成果:
- 在EAM小鼠中,PCSK9抑制显著降低了心脏炎症.
- 在抑制后观察到心脏和外周血液PCSK9水平降低.
- PCSK9在心脏CD4+ T细胞,CD8+ T细胞,巨细胞和心肌细胞中表达.
- 抑制PCSK9通过降低ROR-γt的调节,特别减少了Th17细胞的分化,而不会影响Th1,Th2或Treg细胞.
- 在体外,PCSK9被证明可以直接促进Th17细胞分化.
结论:
- 抑制PCSK9可以改善实验性自身免疫性心肌炎的严重程度.
- 治疗效果是由通过LDLR/STAT3/ROR-γt通路减少Th17细胞分化的介导.
- PCSK9代表了治疗心肌炎的有前途的治疗标.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


